AKT1 (E17K) mutation in pancreatic cancer

Technol Cancer Res Treat. 2008 Oct;7(5):407-8. doi: 10.1177/153303460800700509.

Abstract

The prevalence of a novel somatic mutation (E17K) in the pleckstrin homology domain of AKT1 was investigated in pancreatic cancer using a quantitative pyrosequencing assay. This mutation was un-detectable in pancreatic cancer tissue samples (n=65) and pancreatic cell line (n=10) DNA suggesting that pancreatic cancer progression is mainly dependent on the K-Ras mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cell Line, Tumor
  • Cell Membrane / metabolism
  • Disease Progression
  • Female
  • Genes, ras
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Pancreatic Neoplasms / genetics*
  • Pancreatic Neoplasms / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-akt / genetics*
  • Proto-Oncogene Proteins c-akt / metabolism

Substances

  • Phosphatidylinositol 3-Kinases
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt